Posted by Michael Wonder on 29 May 2025
Eton Pharmaceuticals announces US FDA approval for Khindivi (hydrocortisone) oral solution
28 May 2025 - Commercial launch expected the week of 2 June 2025.
Eton Pharmaceuticals today announced the US FDA approval of a new drug application for Khindivi (hydrocortisone) oral solution as a replacement therapy in paediatric patients five years of age and older with adrenocortical insufficiency.
